Kestra Medical Technologies (KMTS) Operating Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Operating Expenses data on file, last reported at $47.7 million in Q1 2026.

• Quarterly Operating Expenses rose 75.6% year-over-year to $47.7 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $184.4 million (up 91.13% YoY) and the FY2025 annual result came in at $130.6 million, up 52.87% from the prior year.
• Operating Expenses grew to $47.7 million in Q1 2026 per KMTS's latest filing, from $43.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $55.8 million in Q2 2025 and bottomed at $20.8 million in Q1 2024.
• The 3-year median for Operating Expenses is $27.1 million (2025), against an average of $33.5 million.
• Peak annual rise in Operating Expenses reached 156.81% in 2025, while the deepest fall reached 30.36% in 2025.
• Tracing KMTS's Operating Expenses over 3 years: stood at $25.0 million in 2024, then soared by 72.97% to $43.2 million in 2025, then grew by 10.4% to $47.7 million in 2026.
• Per Business Quant, the three latest KMTS Operating Expenses figures stand at $47.7 million (Q1 2026), $43.2 million (Q4 2025), and $37.7 million (Q3 2025).

Peer Comparison